Nurse Practitioner · Stevens Point, WI
NPI
1013234889
Since 2010
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
824 Illinois Ave
Stevens Point, WI, 54481
Phone (715) 342-7500
Groups this clinician bills Medicare through
Medicare paid, 2022
$42K
746 services
Medicare patients, 2022
253
Average age 68
Drug cost, 2024
$4.5M
6,323 prescriptions
Company payments, 2025
$26K
From 7 companies
Procedures and visits billed to Original Medicare, 2022
In 2022, the most common Medicare service billed by Jodi L Strong was code 99214 (office e&m - established), 367 times for 197 patients. In total Jodi L Strong billed 746 services in 15 codes, and Medicare paid $42K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-08-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 367 | 197 | $73.38 | $27K |
| 95251 Test - Miscellaneous | Office | 152 | 78 | $22.04 | $3,351 |
| 99211 Office E&M - Established | Office | 112 | 52 | $13.60 | $1,523 |
| 99215 Office E&M - Established | Office | 53 | 48 | $101.93 | $5,402 |
| 99205 Office E&M - New | Office | 21 | 21 | $128.75 | $2,704 |
Medicare prescription drug claims, 2024
In 2024, the drug Jodi L Strong prescribed most often to Medicare patients was Ozempic (Semaglutide), with 729 prescriptions and refills. In total Jodi L Strong wrote 6,323 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 729 | 1,103 | 139 | $1.1M |
| Jardiance Empagliflozin | 467 | 919 | 96 | $539K |
| Metformin Hcl Er Metformin Hcl | 445 | 1,161 | 118 | $6,202 |
| Mounjaro Tirzepatide | 442 | 554 | 68 | $584K |
| Metformin Hcl Generic | 392 | 1,111 | 116 | $5,348 |
| Pioglitazone Hcl Generic | 329 | 768 | 81 | $3,589 |
| Trulicity Dulaglutide | 326 | 468 | 70 | $464K |
| Tresiba Flextouch U-200 Insulin Degludec | 236 | 520 | 66 | $327K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 226 | 411 | 60 | $35K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 174 | 479 | 69 | $21K |
| Glimepiride Generic | 174 | 441 | 47 | $1,111 |
| Glipizide Er Glipizide | 130 | 343 | 43 | $2,196 |
| Novolog Flexpen Insulin Aspart | 129 | 241 | 49 | $51K |
| Glipizide Generic | 108 | 309 | 39 | $914 |
| Humalog Kwikpen U-100 Insulin Lispro | 97 | 182 | 35 | $45K |
Brand drugs: 3,890 claims; generic drugs: 1,840 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jodi L Strong $26K ($26K in general payments such as food, travel and fees) from 7 companies. The largest payer was Novo Nordisk Inc with $14K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.